Circulating galectin-3 correlates with angiogenetic factors, indicators of nutritional condition and systemic inflammation in patients with thyroid cancer-Reference-Cited by-同舟云学术

Circulating galectin-3 correlates with angiogenetic factors, indicators of nutritional condition and systemic inflammation in patients with thyroid cancer

Published:2016 Issue:1 Volume:24 Page:35-40
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Shimura Tatsuo¹,Shibata Masahiko²,Gonda Kenji²,Nakajima Takahiro³,Chida Shun³,Noda Masaru³,Suzuki Satoshi⁴,Nakamura Izumi⁴,Nakano Keiichi⁴,Fukushima Toshihiko⁴,Suzuki Shinichi⁴,Takenoshita Seiichi³

Affiliation:

1. Department of Cancer Biology and Electronics, Fukushima Medical University

2. Department of Gastrointestinal Oncology, Saitama Medical University International Medical Center

3. Department of Organ Regulatory Surgery, Fukushima Medical University

4. Department of Thyroid and Endocrinology, Fukushima Medical University

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/24/1/24_35/_pdf

Reference38 articles.

1. 1) Franceschi, S., Boyle, P., Maisonneuve, P., La Vecchia, C., Burt, A.D., Kerr, D.J. and MacFarlane, G.J. (1993) The epidemiology of thyroid carcinoma. Crit. Rev. Oncog. 4: 25-52.

2. 2) Fahey, T.J. 3rd., Reeve, T.S. and Delbridge, L. (1995) Increasing incidence and changing presentation of thyroid cancer over a 30-year period. Br. J. Surg. 82: 518-520.

3. 3) DeGroot, L.J., Kaplan, E.L., McCormick, M. and Straus, F.H. (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 71: 414-424. DOI: 10.1210/jcem-71-2-414

4. 4) Samaan, N.A., Schultz, P.N., Hickey, R.C., Goepfert, H., Haynie, T.P., Johnston, D.A. and Ordonez, N.G. (1992) The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J. Clin. Endocrinol. Metab. 75: 714-720.

5. 5) Xing, M., Haugen, B.R. and Schlumberger, M. (2013) Progress in molecular-based management of differentiated thyroid cancer. Lancet 381: 1058-1069. DOI: 10.1016/S0140-6736(13)60109-9

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CLINICAL VALUE OF GALECTIN-3 IN DIFFERENTIATING PAPILLARY THYROID CANCER FROM NODULAR GOITER;Romanian Archives of Microbiology and Immunology;2022-03-31

2. Significance of Circulating Galectin-3 in Patients with Hepato-biliary and Pancreatic Cancer;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2017